As the native peptide, GLP-1 provides the reference pharmacological standard for all GLP-1R binding, signalling, and pathway studies
Medications that have been suggested for the symptoms of fatigue, brain fog, postexertional malaise, orthostatic intolerance, or allergy/inflammation had less often been tried, despite their overall accessibility to generalist clinicians
This is one of the most common questions we hear, and its a fair one
Their potential for disease modification and symptom relief, particularly in specific phenotypes, supports their further exploration as part of a personalized treatment approach
Concerns about the long-term use of Semaglutide include the sustainability of its benefits, especially weight loss and glycemic control, and the potential for chronic side effects or complications